Auto-expansion of

HMGA2 Sleeping Beauty transposase gene therapy helper-dependent adenovirus vector hematopoietic stem cells insertion site analysis in vivo

Journal

Molecular therapy. Methods & clinical development
ISSN: 2329-0501
Titre abrégé: Mol Ther Methods Clin Dev
Pays: United States
ID NLM: 101624857

Informations de publication

Date de publication:
12 Sep 2024
Historique:
received: 15 04 2024
accepted: 08 08 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: epublish

Résumé

We developed an

Identifiants

DOI: 10.1016/j.omtm.2024.101319 PMID: 39282078 PMC: PMC11399618
pubmed: 39282078
doi: 10.1016/j.omtm.2024.101319
pii: S2329-0501(24)00135-9
pmc: PMC11399618
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101319

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

A.L. and P.N.V. receive research funding from Ensoma, Inc. R.E., K.W.M., and R.P. are employees of Ensoma, Inc.

Auteurs

Hongjie Wang (H)

University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.

Aphrodite Georgakopoulou (A)

University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.

Evangelos Nizamis (E)

University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.

Ka Wai Mok (KW)

Ensoma, Inc., Boston, MA, USA.

Raïssa Eluère (R)

Ensoma, Inc., Boston, MA, USA.

Robert A Policastro (RA)

Ensoma, Inc., Boston, MA, USA.

Paul N Valdmanis (PN)

University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.

André Lieber (A)

University of Washington, Department of Medicine, Division of Medical Genetics, Seattle, WA 98195, USA.
University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA 98195, USA.

Classifications MeSH